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Abstract. 
 
Biochemical and genetic evidence suggest 
that the SWI/SNF complex is involved in the remodel-
ing of chromatin during gene activation. We have used 
antibodies specific against three human subunits of this 
complex to study its subnuclear localization, as well as 
its potential association with active chromatin and the 
nuclear skeleton. Immunofluorescence studies revealed 
a punctate nuclear labeling pattern that was excluded 
from the nucleoli and from regions of condensed chro-
matin. Dual labeling failed to reveal significant colocal-
ization of BRG1 or hBRM proteins with RNA poly-
merase II or with nuclear speckles involved in splicing. 
Chromatin fractionation experiments showed that both 
soluble and insoluble active chromatin are enriched in 
the hSWI/SNF proteins as compared with bulk chroma-
tin. hSWI/SNF proteins were also found to be associ-
ated with the nuclear matrix or nuclear scaffold, sug-
gesting that a fraction of the hSWI/SNF complex could 
be involved in the chromatin organization properties 
associated with matrix attachment regions.
 
I
 
t
 
 is becoming clear that structural aspects of chromatin
and the architecture of the nucleus are important fac-
tors in the control of gene expression (Felsenfeld,
1992; Paranjape et al., 1994; Stroboulis and Wolffe, 1996).
DNA in the nucleus is organized into a hierarchy of struc-
tures where the basic building block is the nucleosome.
The packaging of DNA in nucleosomes and higher order
structures represents an obstacle to the binding of specific
proteins (Laybourn and Kadonaga, 1991) and RNA poly-
merases (Williamson and Felsenfeld, 1978) to control ele-
ments and transcription initiation sites. The same is true
for transcriptional elongation. A convergence of biochem-
ical and genetic studies has identified several ATP-depen-
dent multiprotein complexes that may help transcriptional
activators to overcome chromatin-mediated repression
(Kingston et al., 1996). The SWI/SNF complex is one of
these complexes. The 
 
SWI
 
 (for mating type switching) and
 
SNF
 
 (for sucrose nonfermenting) genes were first identi-
fied in yeast (
 
SWI
 
/
 
SNF
 
 gene complex) by mutations inter-
fering with the activation of several inductible promoters
(for review see Carlson and Laurent, 1994; Peterson and
Tamkun, 1995; Peterson, 1996). Alterations in each of the
four histones and in some presumed chromatin structural
proteins all result in partial suppression of the impaired tran-
scriptional phenotype of swi or snf mutations (Winston
and Carlson, 1992). Genetic and biochemical analysis dem-
onstrated that SWI and SNF proteins function together as
one multisubunit complex (Peterson and Hershkowitz,
1992; Cairns et al., 1994; Peterson et al., 1994) able to facil-
itate the binding of activator proteins to nucleosomal
DNA in an ATP-dependent way (Côté et al., 1994).
Within SWI/SNF proteins, SNF2 is of special interest. It
contains sequence motifs closely related to those found in
DNA-dependent ATPases and helicases (Laurent et al.,
1993), and, indeed, bacterially expressed SNF2 protein
shows DNA-dependent ATPase activity. These data suggest
that SNF2 is an essential component of the ATPase-depen-
dent remodeling activity of the complex.
Several groups have demonstrated that a complex ho-
mologous to the yeast SWI/SNF complex exists in higher
eukaryotes (Kwon et al., 1994; Wang et al., 1996
 
a
 
,
 
b
 
). One
of the first relatives of SWI2/SNF2 to be discovered was
brahma (brm), an activator of 
 
Drosophila
 
 homeotic genes
(Tamkun et al., 1992). brm was identified in a screen for
suppressors of mutations in polycomb, a repressor of ho-
meotic genes that is thought to act by altering chromatin
structure. Humans have at least two genes closely related
 
to SWI2/SNF2: 
 
hBRM
 
 (human brahma or hSNF2
 
a
 
) and
 
BRG1
 
 (brahma-related gene 1 or hSNF2
 
b
 
) (Muchardt and
Yaniv, 1993; Khavari et al., 1993; Chiba et al., 1994). Both
hBRM and BRG1 have been shown to enhance transcrip-
tional activation by the glucocorticoid receptor (Muchardt
and Yaniv, 1993; Chiba et al., 1994) through a mechanism
 
that may also involve the retinoblastoma (Rb)
 
1
 
 protein
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Abbreviations used in this paper
 
: CTD, carboxy-terminal domain;
DAPI, 4
 
9
 
,6-diamidino-2-phenylindole; GR, glucocorticoid receptor; LIS,
3,5-diiodosalicilic acid, lithium salt; MAR, matrix-associated region; SAR,
scaffold-associated region; Rb, retinoblastoma; RNAP II, RNA poly-
merase II.
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(Dunaief et al., 1994; Singh et al., 1995). Human homo-
logues of SNF5 and SWI3 have also been cloned (Kalpana
et al., 1994; Muchardt et al., 1995; Wang et al., 1996
 
b
 
). In
addition, human SWI/SNF complexes containing hSNF5,
either BRG1 or hBRM proteins, and seven to ten addi-
tional BRG1-associated factors have been purified from
different cell lines (Wang et al., 1996
 
a
 
). Like the yeast
complex, the human SWI/SNF complexes show, in vitro,
nucleosome remodeling activity and facilitate the binding
of activators to nucleosomal DNA (Imbalzano et al., 1994;
Kwon et al., 1994; Wang et al., 1996
 
a
 
).
The high degree of similarity between BRG1 and hBRM
raises the possibility that they may be functionally redun-
dant. On the other hand, we have observed that BRG1
and hBRM are phosphorylated during mitosis, and, while
hBRM is partially degraded, the levels of BRG1 remain
constant throughout the cell cycle (Muchardt et al., 1996).
These results suggest that the two proteins may play dis-
tinct roles during the cell cycle.
Recently, it has been proposed that the yeast SWI/SNF
complex copurifies with the holoenzyme fraction of RNA
polymerase II (RNAP II), suggesting that interaction with
RNAP II may be the mechanism by which SWI/SNF com-
plex is recruited to its genomic targets (Wilson et al., 1996).
However, the SWI/SNF complex can also be isolated from
yeast without an associated holoenzyme (Cairns et al., 1994;
Côté et al., 1994). At present, it is unclear whether the hu-
man SWI/SNF proteins are also associated with the RNAP
II holoenzyme. In addition, it was also demonstrated that
the yeast SWI/SNF complex contains a DNA binding ac-
tivity that may target it directly to specific DNA structures
(Quinn et al., 1996). These examples demonstrate that the
mechanism involved in the recruitment of the SWI/SNF
complex to its targets in the chromatin, in vivo, remains
unclear.
Nuclear fractionation studies have shown that transcrip-
tionally active DNA is tightly associated with the nuclear
skeleton or nuclear matrix, while inactive loci are not (Strat-
ling, 1987; Jackson and Cook, 1985; Jackson et al., 1993).
The nuclear matrix is operationally defined as the nuclear
structure that remains after the salt extraction of nuclease-
treated nuclei. It consists of a peripheral lamina–pore com-
plex and an internal filamentous ribonucleoprotein net-
work that has not been well characterized (for review see
Berezney et al., 1995). This component of the nuclear ar-
chitecture provides the internal scaffold of the nucleus.
The matrix- or scaffold-associated DNA regions (MARs
or SARs) may function as boundary elements for tran-
scriptional domains and confer position-independent ex-
pression of associated genes in transgenic mice (Laemmli
et al., 1992; Jenuwein et al., 1993). Biochemical studies
have also demonstrated that transcriptionally active chro-
matin exhibit increased sensitivity to nucleases. These ob-
servations explain why a fraction of actively transcribed
chromatin is easily solubilized after nuclease treatment of
isolated nuclei while the rest is tightly bound to the nu-
clear matrix (Kamakaka and Thomas, 1990; Davie, 1995).
In the present study we have used specific antibodies that
recognize BRG1, hBRM, and hSNF5 to study the subnu-
clear localization of the human SWI/SNF complex. Immu-
nofluorescent staining revealed a punctate distribution of
BRG1 and hBRM in interphase HeLa nuclei, the lowest
 
concentration appearing in regions of high DNA density.
However, we failed to show strong overlap between
hBRM or BRG1 and RNA polymerase II staining. Chro-
matin fractionation demonstrated that three components
of the hSWI/SNF complexes (BRG1, hBRM, and hSNF5)
were enriched in highly transcribed chromatin and associ-
ated with the nuclear matrix. Association with chromatin
or nuclear structures was abolished during mitosis. Finally,
we show that hSWI/SNF complexes can be released from
the nucleus by incubation with ATP and that this process
is inhibited by protein kinase inhibitors.
 
Materials and Methods
 
Cell Culture and Cell Cycle Synchronization
 
HeLa cells were grown at 37
 
8
 
C in 7% CO
 
2
 
 in DME (GIBCO BRL, Gaith-
ersburg, MD) supplemented with 7% FCS. For cell cycle synchronization,
exponentially growing cells were treated with 5 mM thymidine for 40 h.
Cells were then released from the block, and samples were taken at differ-
ent times for flow cytometry analysis and for extract preparation. 12 h af-
ter the thymidine block release, 0.1 
 
m
 
g/ml nocodazole was added to the
medium to block the cells in mitosis.
 
Isolation of Cell Nuclei and Total Extract
 
The procedure was adapted from Cereghini et al. (1988). 10
 
7
 
 cells were
resuspended in 200 
 
m
 
l of HNB (0.5 M sucrose, 15 mM Tris-HCl, pH 7.5,
60 mM KCl, 0.25 mM EDTA, pH 8, 0.125 mM EGTA, pH 8, 0.5 mM sper-
midine, 0.15 mM spermine, 1 mM DTT, 0.5 mM PMSF, 5 
 
m
 
g/ml pepstatin,
5 
 
m
 
g/ml leupeptin, and 5 
 
m
 
g/ml aprotinin). Then 100 
 
m
 
l of HNB supple-
mented with 1% NP-40 was added dropwise. After 5 min of incubation at
4
 
8
 
C, nuclei were pelleted by centrifugation at 6,000 rpm for 3 min.
When total extract was required, 10
 
7
 
 cells were lysed in 200 
 
m
 
l of urea
buffer (8 M urea, 0.1 M NaH
 
2
 
PO
 
4
 
, 0.01 M Tris, pH 8). The protein concen-
tration was determined by Bradford assays (Bradford, 1976).
 
Nuclear Matrix Isolation
 
High salt isolation of nuclear matrix was carried out essentially as de-
scribed (He et al., 1990). After wash in PBS, cells were extracted in cy-
toskeleton buffer (CSK): 10 mM Pipes, pH 6.8, 100 mM NaCl, 300 mM su-
crose, 3 mM MgCl
 
2
 
, 1 mM EGTA, supplemented with leupeptin, aprotinin,
and pepstatin (1 
 
m
 
g/ml each), 1 mM PMSF, 1 mM DTT, and 0.5% (vol/
vol) Triton X-100. After 3 min at 4
 
8
 
C, the cytoskeletal frameworks were
separated from soluble proteins by centrifugation at 5,000 
 
g
 
 for 3 min.
Chromatin was solubilized by DNA digestion with 1 mg/ml of RNase-free
DNAase I in CSK buffer plus proteinases inhibitors for 15 min at 37
 
8
 
C.
Then ammonium sulfate was added from a 1 M stock solution in CSK
buffer to a final concentration of 0.25 M and, after 5 min at 4
 
8
 
C, samples
were pelleted again. The pellet was further extracted with 2 M NaCl in
CSK buffer for 5 min at 4
 
8
 
C, and then centrifuged. This treatment re-
moved all the DNA and the histones from the nucleus, as shown by agar-
ose gel electrophoresis and SDS-PAGE, respectively. The remaining pel-
let was solubilized in urea buffer and was considered the nuclear matrix–
containing fraction.
For low salt preparation of nuclear matrix and scaffolds, nuclei were
isolated as described by Mirkovitch et al. (1984). Nuclei were then stabi-
lized in isolation buffer (3.75 mM Tris HCl, pH 7.5, 0.05 mM spermine,
0.125 mM spermidine, 0.5 mM EDTA, 5 mM MgCl
 
2
 
, 20 mM KCl) for 20
min at 37
 
8
 
C, and then DNA was digested by incubation under the same
conditions for another 15 min in the presence of 1 mg/ml of RNase-free
DNAase I. After centrifugation, nuclei were washed with isolation buffer
and extracted with the same buffer supplemented with 25 mM 3,5-diio-
dosalicilic acid, lithium salt (LIS) for 5 min at room temperature. Chroma-
tin-depleted nuclei were recovered by centrifugation and the pellet was
solubilized in urea buffer.
 
Chromatin Fractionation
 
Isolation of S1, S2, and P fractions from HeLa nuclei chromatin was per-
formed according to the method of Rose and Garrard (1984) with minor 
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modifications. 10
 
7
 
 nuclei were isolated as described above and resus-
pended in 200 
 
m
 
l of nuclear buffer (20 mM Tris-HCl, pH 7.5, 70 mM NaCl,
20 mM KCl, 5 mM MgCl
 
2
 
, and 3 mM CaCl
 
2
 
 supplemented with protease
inhibitors). Nuclei suspension was incubated with 3 U of micrococcal nu-
clease (Sigma Chemical Co., St. Louis, MO) at room temperature during
the indicated time. The digestion was terminated by the addition of EDTA
and EGTA to 5 mM each, the mixture was then centrifuged at 5,000 
 
g
 
 for
3 min, and the supernatant was designated the S1 fraction. The nuclear
pellet was lysed in 2 mM EDTA for 15 min at 4
 
8
 
C. This was followed by
centrifugation, and the supernatant and the pellet were designated the S2
and P fractions, respectively. For DNA analysis of S1, S2, and P fractions,
aliquots were treated with lysis buffer (50 mM Tris-HCl, pH 7.5, 100
mM NaCl, 5 mM EDTA, 0.5% SDS) for 1 h at 37
 
8
 
C and with phenol-
CHCl
 
3
 
 extraction. Proteins were analyzed by SDS-PAGE. After 2 min of
micrococcal nuclease digestion, S1, S2, and P contained 
 
z
 
5%, 80%, and
15% of the total DNA, respectively.
 
Immunoblotting and Antibodies
 
Immunoblotting was carried out according to standard procedures. Pro-
teins were separated by SDS-PAGE (Laemmli, 1970) and transferred to
nitrocellulose. The membrane was then blocked with PBS/0.2% Tween-
20/10% horse serum and incubated with the various antibodies. Enhanced
chemiluminescence reagents (ECL; Amersham, Les Ulis, France) were
used for detection. The mAb pol 3/3 recognizes the RNAPII largest sub-
unit at an evolutionary conserved epitope located outside the carboxy-ter-
minal domain (CTD) (Krämer et al., 1980) and was kindly provided by O.
Bensaude (Ecole Normal Superieure, Paris, France). The monoclonal
CC3 antibody was raised against a nuclear p255 phosphoprotein (Thi-
bodeau et al., 1989) and provided by M. Vincent (Université Laval,
Sainte-Foy, Quebec, Canada). Recently, it has been demonstrated that the
epitope recognized by this antibody corresponds to a subpopulation of hy-
perphosphorylated RNAPII largest subunit (Vincent et al., 1997; Dubois et
al., 1997). Antibodies against BRG1, hBRM, hSNF5, and JunB have been
previously described (Muchardt et al., 1995, 1996; Pfarr et al., 1994). To
prepare anti–glucocorticoid receptor antibodies, rabbits were immunized
with an 
 
Escherichia coli
 
–expressed chimeric protein spanning amino acids
106–318 plus 407–556 from the human glucocorticoid receptor protein.
 
Indirect Immunofluorescence Analysis
 
HeLa cells, grown on coverslips, were fixed in 3.5% freshly prepared
paraformaldehyde in PBS for 10 min at room temperature, and then per-
meabilized with 0.05% Triton X-100 in PBS for 30 min at room tempera-
ture. Alternatively, cells were permeabilized with ice-cold CSK buffer
supplemented with 0.5% Triton X-100 for 3 min, before fixation. For in
situ isolation of nuclear matrix, cells were extracted directly on the cover-
slips with the high salt method described above, and then fixed with 4%
paraformaldehyde in PBS. To enhance exposure of hidden epitopes, cells
were treated with 6 N guanidine hydrochloride as described previously
(Peränen et al., 1993). In all cases, the coverslips were incubated overnight
with the appropriate antibodies in PBS/10% horse serum/0.1% Tween-20.
Fluorescein- or Texas red–linked anti–rabbit or anti–mouse antibodies
from Amersham were used for detection. The cellular DNA was labeled
with 0.05% 4
 
9
 
,6-diamidino-2-phenylindole (DAPI) or propidium iodide.
The preparations were observed at 
 
3
 
100 magnification with an Axiophot
microscope (Zeiss, Oberkochen, Germany) or at 
 
3
 
100 magnification with
a confocal microscope using a 488-nm laser and a 535-nm narrow band fil-
ter for the FITC signal, and a 568-nm laser and a 590-nm long band filter
for Texas red and propidium iodide signal.
 
ATP-dependent Release of hSWI/SNF from Cell Nuclei
 
Nuclei from HeLa cells were isolated as described above. 10
 
7
 
 nuclei were
washed in 1 ml of nuclear buffer, centrifuged, and resuspended in 100 
 
m
 
l
of the same buffer. 10-
 
m
 
l aliquots were incubated for 1 h at 30
 
8
 
C in the
presence or absence of 3 mM ATP. When indicated, 3 mM of adenosine
5
 
9
 
-(
 
b
 
, 
 
g
 
-methylene) triphosphate (AMP-PCP) or adenosine 5
 
9
 
-
 
O
 
-(3-thio-
triphosphate) (ATP
 
g
 
S) was added to the reaction.
For in situ ATP-dependent release of BRG1 and hBRM, HeLa cells
grown on coverslips were permeabilized with 0.5% Triton X-100–CSK
buffer as previously described and incubated in nuclear buffer (see above)
with or without ATP for 1 h at room temperature. Afterward, cells were
washed with PBS and fixed with paraformaldehyde.
 
Results
 
Subnuclear Immunolocalization of hBRM and BRG1
 
We have previously described the characterization of af-
finity-purified polyclonal antibodies that specifically rec-
ognize BRG1 or hBRM proteins (
 
a
 
-BRG1 and 
 
a
 
-hBRM,
respectively). In immunofluorescence studies, these anti-
bodies revealed a strictly nuclear signal except in mitotic cells
where hBRM and BRG1 signals were found to be ex-
cluded from the regions containing the condensed chro-
mosomes (Muchardt et al., 1996). A more detailed analysis
of the labeling pattern of HeLa cells, using confocal micro-
scopy, revealed a diffuse nucleoplasmic signal and a vari-
able number of bright dots or foci (Fig. 1 
 
A
 
). Furthermore,
hBRM and BRG1 staining was excluded from the nucleoli
and from regions of highly condensed heterochromatin,
which are stained brightly by propidium iodide. hBRM
and, to a lesser extent, BRG1 were also excluded from the
periphery of the nucleus. It is known that transcriptionally
inactive heterochromatin is adjacent to the inner nuclear
membrane (Mathog et al., 1984). These data suggest that
hSWI/SNF complex is excluded from heterochromatin.
The intranuclear distribution of both proteins was the
same in cells that were extracted with Triton X-100 before
fixation or in nonextracted cells.
It has been reported that the yeast SWI/SNF proteins
are integral components of the RNAP II holoenzyme, be-
ing part of the SRB (suppressor of RNA polymerase B)
complex. This complex is tightly associated with the RNAP II
large subunit CTD (Wilson et al., 1996). To test if human
SWI/SNF complexes are associated with RNAP II in situ,
we looked for potential colocalization between hBRM or
BRG1 and RNAP II. Two mAbs against the largest subunit
of RNAP II (RNAP II-LS) were used: the pol 3/3 antibody
recognizes nonphosphorylated and phosphorylated forms
of RNAP II-LS, and the cc-3 antibody recognizes a sub-
population of hyperphosphorylated RNAP II-LS (Vincent
et al., 1997; Dubois et al., 1997) located in 20–30 discrete
nuclear foci (Bisotto et al., 1995). These foci are closely
linked to speckle domains (irregularly shaped intranuclear
regions that contain splicing factors) and colocalize with
the splicing factor SC-35 (Bisotto et al., 1995; Bregman et
al., 1995; Mortillaro et al., 1996). Combination of 
 
a
 
-hBRM
or 
 
a
 
-BRG1 labeling and pol 3/3 or cc-3 labeling was per-
formed and analyzed by confocal microscopy (Fig. 1, 
 
B–E
 
).
Pol 3/3 antibodies revealed a punctate staining pattern
throughout the nucleus that was excluded from the nucle-
oli. Although some colocalization could be observed (Fig.
1, 
 
B
 
 and 
 
C
 
, 
 
right panels
 
, 
 
yellow
 
), a large fraction of the
hBRM or BRG1 dots showed little or no RNAP II stain-
ing and vice versa. We analyzed the degree of colocaliza-
tion quantitatively by plotting the pixel intensity distribu-
tion of a dual-channel section (two-dimensional scatter
plot diagram) or by plotting the signal intensities of the
red and the green signals along a single line drawn
through the image of a doubly labeled nucleus (not
shown). These plots show that there is no clear correlation
between the spatial distribution of hBRM or BRG1 and
RNAP II. The cc3 antibody recognized 20–30 brightly
stained foci. hBRM- and BRG1-containing dots did not
colocalize with these foci either (Fig. 1, 
 
D
 
 and 
 
E
 
). It has 
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also been reported that RNAP II inhibitors like 
 
a
 
-aman-
itin or actinomycin D provoke a redistribution of RNA pol
II and an increased concentration of the enzyme in the
speckles (Bregman et al., 1995). Treatment of HeLa cells
with such inhibitors provoked an enlargement of the
speckles (around twofold surface increase), revealed by
the cc-3 antibody, but did not produce any reorganization
of the signals revealed by the 
 
a
 
-BRG1 or 
 
a
 
-hBRM anti-
bodies (data not shown). These data suggest that a large
fraction of the hSWI/SNF complex is not associated with
RNAP II and vice versa.
 
hSNF/SWI Complex Is Partially Associated with the 
Nuclear Matrix
 
To get further insight on the association of hSWI/SNF com-
ponents with the nucleus, different procedures were tested
for their ability to release the hSWI/SNF complex from
HeLa nuclei. More than 60% of the amount of hBRM,
BRG1, and hSNF5 proteins was found to be resistant to
extraction with detergents and 0.45 M NaCl or 100 mM
MgCl
 
2
 
, even after total DNA digestion with DNase I (data
not shown). Such treatments are normally used to extract
chromatin components including high mobility group pro-
teins, transcription factors, or histones. To investigate the
possibility that the hSWI/SNF complex may bind to the
nuclear skeleton or nuclear matrix, we isolated the nuclear
matrix by the sequential extraction procedure of He et al.
(1990). In the first fractionation step, soluble proteins are
removed by extraction with Triton X-100. Chromatin pro-
teins are then released by DNase I digestion and extrac-
tion with 0.25 M ammonium sulfate. 95% of the histones
were extracted in this step (data not shown). After wash-
ing with 2 M NaCl, the last fraction is composed of struc-
Figure 1. Subnuclear distribution of hBRM and BRG1 proteins in HeLa cells. HeLa cells grown on coverslips were fixed with 3% para-
formaldehyde. (A) After fixation, cells were labeled with a-hBRM (top left) or a-BRG1 (top right) and detected with a fluorescein-
conjugated secondary antibody, using confocal microscopy. Cellular DNA was stained with propidium iodide (PI) (middle). Superimpo-
sition of antibody staining and PI (bottom). (B and C) Fixed cells were double labeled with pol 3/3 mAbs against the RNAP II-LS (visualized
with fluorescein; middle) and a-BRG1 (B) or a-hBRM (C) (visualized with Texas red; left). Confocal images from each fluorochrome
were recorded and superimposed (green staining for RNAP II-LS protein and red staining for hBRM or BRG1; right). Regions of colo-
calization (yellow). (D and E) Fixed cells were double labeled with cc3 mAbs against CTD-hyperphosphorylated RNAP II (visualized
with fluorescein; middle) and a-BRG1 (D) or a-hBRM (E) (visualized with Texas red; left). Confocal images from each fluorochrome
were recorded and superimposed (green staining for CTD-hyperphosphorylated RNAP II protein and red staining for hBRM or BRG1;
right). Regions of colocalization (yellow). Intensities were adjusted for maximum contrast. Bar, 5 mm. 
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tural nuclear matrix proteins and nuclear matrix–associ-
ated proteins. Supernatants from each extraction step and
the final nuclear matrix pellet were analyzed by SDS-
PAGE and immunoblotting. As shown in Fig. 2 A, z50%
of the BRG1, hBRM, and hSNF5 proteins were released
with the chromatin proteins, while the remainder was
tightly associated with the nuclear matrix proteins. This
was compared with the distribution of other nuclear pro-
teins. It has been shown previously that a fraction of hypo-
phosphorylated Rb protein is associated with the nuclear
matrix (Mancini et al., 1994). In our extracts, hyperphos-
phorylated Rb appeared in the first fraction together with
soluble proteins. Most hypophosphorylated Rb was re-
leased in the Triton X-100 extraction or in the chromatin
fraction, while z20% was found in the insoluble nuclear
matrix pellet (Fig. 2 A). It has also been reported that glu-
cocorticoid receptor and other nuclear receptors are asso-
ciated with the nuclear matrix (van Steensel et al., 1995b).
Indeed, our nuclear matrix preparations contained z50%
of the nuclear glucocorticoid receptor (GR) from dexa-
methasone-treated HeLa cells. However, in nontreated
cells, all the GR was found in the cytoplasmic fraction
(Fig. 2 A). In contrast, the transcription factor JunB and
the large subunit of the RNAP II (revealed by the pol 3/3
antibody) were fully extracted in the chromatin fraction,
indicating that nuclear matrix preparations were not con-
taminated with all transcription factors. Finally, we also
used an antibody against lamin B, one of the major com-
ponents of the nuclear matrix, as a marker to verify that
cytoplasmic and chromatin fractions were not contami-
nated with nuclear matrix proteins. As expected, lamin B
was solely found in the nuclear matrix fraction (Fig. 2 A).
The possibility has been raised that the high salt extrac-
tion procedure used for nuclear matrix preparations in-
duces the precipitation of some nuclear proteins (Kirov and
Tsanev, 1986). To verify the observations described above
with a method that avoids high salt conditions, we used the
procedure of Mirkovich et al. (1984). This protocol entails
stabilization of nuclei by a brief incubation at elevated tem-
perature, followed by extraction of histones and other
chromatin components with detergent-like LIS and diges-
tion of the genomic DNA. The resulting structures have
been termed nuclear scaffolds (Mirkovich et al., 1984). When
nuclear scaffolds were isolated by this method, z50% of
hBRM and BRG1 proteins were extracted in the LIS-solu-
ble fraction, together with chromatin proteins, whereas
the other 50% appeared in the nuclear scaffold prepara-
tion (Fig. 2 B). However, LIS solubilized a large fraction
Figure 2. A fraction of the
hSWI/SNF complex is associ-
ated with nuclear matrix. (A)
HeLa nuclear matrix was pre-
pared by the high salt method
as described in Materials and
Methods. Cells were sequen-
tially extracted with 0.5%
Triton X-100 (Cytoplasm),
DNase I and 0.25 M (NH4)2SO4
(Chromatin), and 2 M NaCl
(Wash 2M NaCl), and the re-
maining pellet was solubilized
in 8 M urea (Nuclear Matrix).
An equivalent aliquot of each
step of the extraction proto-
col was subjected to SDS-
PAGE and immunoblotted
with the indicated antibodies.
RNAP II-LS was detected
with pol 3/3 antibodies. When
indicated, HeLa cells were
treated with 1026 M of dexa-
methasone (DEX). (B)
HeLa  nuclear matrix was
prepared by the LIS method
as described in Materials and
Methods. Cells were sequen-
tially extracted with 0.5%
Triton X-100, DNase I, 25
mM LIS in low ionic strength
buffer, and low-ionic strength
buffer, and finally the pellet
was resuspended in urea
buffer (Nuclear Matrix). An
equivalent aliquot of each
step of the extraction proto-
col was subjected to SDS-
PAGE and immunoblotted
with the indicated antibodies.The Journal of Cell Biology, Volume 137, 1997 268
of the hSNF5 protein, suggesting that the LIS treatment
may disrupt the hSWI/SNF complex or the association of
hSNF5 with other members of the complex (Fig. 2 B).
Taken together, these data demonstrate that the hSWI/
SNF complex is distributed among different compartments
of the nucleus. The existence of several hSWI/SNF com-
plexes with distinct subunit composition (Wang et al.,
1996a) opens the possibility that nuclear matrix–associ-
ated and nonassociated complexes may have a partially
different subunit composition.
To investigate whether the distribution of hBRM and
BRG1 proteins is similar in whole nuclei and in nuclear
matrices, we used a-hBRM and a-BRG1 antibodies in in-
direct immunofluorescence analysis of the nuclear mate-
rial remaining after in situ sequential DNase I and high
salt extraction. As shown in Fig. 3, the labeling pattern was
similar for both proteins before and after extraction, but
the intensity of the signal decreased in extracted nuclei. As
expected, the DAPI signal disappeared completely in the
nuclear matrix preparations (Fig. 3 B). a-lamin B antibod-
ies gave a strong signal in the nuclear lamina and a much
weaker, diffuse signal in the nucleoplasm. The intensity of
the signal was similar in whole nuclei and in extracted nu-
clei; however, lamina of extracted nuclei appeared slightly
deformed or broken, probably as a result of the osmotic
shock occurring during the extraction procedure (Fig. 3 B).
hSWI/SNF Proteins Are Enriched in Active Chromatin
In the previously described nuclear matrix isolation proto-
col, .95% of chromatin was solubilized in a single fraction.
To try to partition between active and inactive chromatin,
we have used an established fractionation procedure in
which nuclei are subjected to mild digestion with micro-
coccal nuclease and subsequent extraction with EDTA
(Huang and Garrard, 1989; Rose and Garrard, 1984). Af-
Figure 3. In situ extraction of nuclear
matrix. (A) Immunofluorescent
staining of nonextracted HeLa cells
with a-BRG1, a-hBRM, and a-lamin
B antibodies. (B) Immunofluores-
cent staining pattern of in situ pre-
pared nuclear matrices with a-BRG1,
a-hBRM, and a-lamin B antibod-
ies. Microscopy and photography
parameters were standardized for
all of the images. Bar, 10 mm.Reyes et al. Subnuclear Localization of hSWI/SNF Complex 269
ter nuclease treatment of HeLa cell nuclei for 1, 2, or 4
min and centrifugation, the supernatant fraction S1 con-
tained between 1% and 8% of the total cellular DNA. The
pellet was then resuspended in 2 mM EDTA, recentri-
fuged, and separated into a second supernatant fraction S2
and a pellet P, which contained z80% and 15% of the to-
tal DNA, respectively. As shown by DNA analysis in aga-
rose gel, the S1 and S2 fractions represent differences in
the nuclease accessibility of chromatin (Fig. 4 A). Fraction
S1 is mainly composed of mononucleosomal-sized DNA
fragments, whereas the S2 fraction contained a typical nu-
cleosomal ladder of DNA fragments. The P fraction con-
tained heterogeneous-sized DNA that remained bound to
the nuclear scaffold after the fractionation. This fraction
has also been called insoluble chromatin (Xu et al., 1986).
It has been shown that S1 and P fractions are enriched in
transcriptionally active DNA, whereas fraction S2 is de-
pleted of transcribed sequences (Rose and Garrard, 1984).
Aliquots of S1, S2, and P fractions were subjected to SDS-
PAGE followed by electrotransfer to nitrocellulose mem-
branes and by immunoblot analysis. As shown in Fig. 4 B,
BRG1, hBRM, and hSNF5 proteins were enriched in frac-
tions S1 and P with respect to fraction S2. This enrichment
appears to be higher for hBRM and hSNF5 than for
BRG1 (around two- to threefold for BRG1, 10–15-fold for
hBRM, and 20–30-fold for SNF5). Since fraction S2 con-
tained the major part of the DNA, abundance of the
hSWI/SNF proteins including BRG1, relative to DNA,
was very low in this fraction. These data suggest that the
hSWI/SNF complex is mostly concentrated in regions
highly sensitive to micrococcal nuclease and in the fraction
of the transcriptionally active chromatin that remains
bound to the nuclear pellet after digestion. On the con-
trary, RNAP II was only found in fraction P, consistent
with reports that demonstrate that transcriptional activity
is associated with an insoluble phase of the nucleus (Jack-
son and Cook, 1985). Although at first view contradictory,
this result is compatible with the fact that RNAP II was
found in the soluble fraction in the experiments described
in Fig. 2. RNAP II is extractable from the nucleus with the
high salt concentration used in the nuclear matrix isolation
protocol, but not with the low ionic strength buffers used
in the chromatin fractionation protocol.
Association of BRG1 and hBRM with the Nuclei during 
the Cell Cycle
We have recently demonstrated that hBRM and BRG1
are phosphorylated in mitotic cells. The phosphorylated
forms of the proteins are localized in the entire cell vol-
ume with exclusion from the condensed chromosomes
(Muchardt et al., 1996). To determine more accurately the
moment at which phosphorylation occurs and to pinpoint
whether a correlation exists between the nature of the nu-
clear association of the hSWI/SNF complex and the posi-
tion in the cell cycle, we have fractionated nuclei of HeLa
cells synchronized at various stages of the cycle. Exponen-
tially growing HeLa cells were blocked with thymidine
(S-phase arrest) for 40 h, and then released from the
block. Flow cytometry analysis revealed that after 12 h
z95% of the cells contained a 4 N chromosomal content
(Fig. 5 A). However, only z15% of the cells had entered
mitosis, as determined by phase-contrast microscopy. At
that time, nocodazole was added to the medium to block
the cells in mitosis. Samples were taken at different times
and total extracts were prepared. Alternatively, cells were
subjected to the DNase I–high salt fractionation protocol
described above. As shown in Fig. 5 B, both BRG1 and
hBRM were phosphorylated at the time when cells en-
tered mitosis but not in S and G2 phases. Both BRG1 and
hBRM remained associated with the nuclear matrix dur-
ing G1, S, and G2 phases (Fig. 5 C). However, all of the
Figure 4. Active chromatin is enriched in hSWI/SNF compo-
nents. 107 nuclei were subjected to partial digestion by micrococ-
cal nuclease for the indicated times and separated into superna-
tant (S1) and pellet. The pellet was extracted with EDTA and
centrifuged to yield supernatant (S2) and pellet (P) chromatin
fractions. (A) DNA from each fraction was electrophoresed in 1%
agarose gels and stained with ethidium bromide. M, 100-bp stan-
dards. (B) An equivalent volume of each fraction was subjected to
SDS-PAGE and immunoblotted with a-BRG1, a-hBRM, a-SNF5,
and pol 3/3 (anti-RNAP II-LS) antibodies.The Journal of Cell Biology, Volume 137, 1997 270
signal appeared in the cytoplasmic fraction in mitotic cells,
consistent with the breakdown of the nuclear structure at
mitosis and the exclusion of hBRM and BRG1 from the
condensed chromatin as previously published (Muchardt
et al., 1996).
ATP-dependent Release of BRG1 and hBRM from
the Nucleus
We further investigated the mechanisms that influence the
binding of SWI/SNF complex to its targets in chromatin
and in the nuclear matrix (Muchardt et al., 1996). BRG1
and hBRM are phosphorylated very late in G2 phase or at
the beginning of mitosis, coinciding with their exclusion
from the condensed chromatin. Therefore, we tested if in-
cubation of isolated HeLa nuclei with mitotic cell extracts
in the presence of ATP would release BRG1 and hBRM
from the nuclei. As a control, nuclei were also incubated
with ATP in the absence of mitotic cell extract or without
ATP. Surprisingly, release of BRG1 and hBRM from the
nucleus depended only on the presence of ATP but not on
the presence of mitotic extract (data not shown). We there-
fore investigated the ATP-dependent release of hBRM
and BRG1 from the nucleus using immunofluorescence.
HeLa cells grown on coverslips were permeabilized in iso-
tonic buffer supplemented with 0.5% Triton X-100,
washed, and then incubated for 1 h in the presence or ab-
sence of 3 mM ATP before fixation with paraformalde-
hyde. Immunofluorescent staining of these cells, using
a-BRG1,  a-hBRM, or a-lamin B antibodies, revealed that
BRG1 and hBRM, but not lamin B, were released from
the nuclei of the ATP-treated cells (Fig. 6). The release of
hBRM after incubation of nuclei with ATP could also be
followed by immunoblotting (Fig. 7), demonstrating that
hBRM was not degraded. Incubation of the nuclei with
nonhydrolyzable ATP analogues like AMP-PCP or ATPgS
had essentially no effect on the release of hBRM from the
nucleus (Fig. 7 A). In addition, the presence of ATPgS to-
gether with ATP decreased the quantity of released
hBRM (Fig. 7 A).
To verify whether this process involved a protein kinase
activity, we have incubated HeLa nuclei with ATP in the
presence of several kinase inhibitors: H7, an inhibitor of
serine and threonine kinases (Hidaka et al., 1984); geni-
stein, a tyrosine kinase inhibitor (Akiyama and Ogawara,
1991); or a cdc2 peptide that competitively inhibits phos-
Figure 5. Association of BRG1 and hBRM with the nuclear matrix in synchronized HeLa cells. (A) HeLa Cells were synchronized by
treatment with thymidine for 40 h. After release of the block (t 5 0), samples were taken at the indicated time for flow cytometry analy-
sis. 12 h later nocodazole was added at 0.1 mg/ml final concentration. (B) Synchronized cells were taken at the indicated time and total
extracts were prepared. Equal quantities of protein were subjected to SDS-PAGE in 5% acrylamide gels and immunoblotted with a-BRG1
and a-hBRM antibodies. Phosphorylated and unphosphorylated BRG1 and hBRM are indicated. (C) Synchronized cells were taken at
the indicated time and fractionated as described in Fig. 2. Cytoplasmic (Cy), chromatin (Chr), and nuclear matrix (NM) fractions were
electrophoresed in 5% acrylamide gels and immunoblotted with a-BRG1 and a-hBRM antibodies.Reyes et al. Subnuclear Localization of hSWI/SNF Complex 271
phorylation by cyclin-dependent kinases (Kemp and Pear-
son, 1991). As shown in Fig. 7 B, genistein and a high con-
centration of the cdc2 peptide strongly inhibited the release
of hBRM from the nuclei (the same results were obtained
for BRG1), suggesting that phosphorylation by several
distinct protein kinases or by a cascade of activating ki-
nases is involved in the release of BRG1 and hBRM from
the nuclear structure. However, ATP-released hBRM pro-
tein was not phosphorylated in the same way as in mitotic
cells, as deduced by the absence of a change in its electro-
phoretic mobility (Fig. 7).
Discussion
To investigate the step(s) in gene activation in which the
hSWI/SNF complex operates, we have compared the spa-
tial distribution and the characteristics of the association
of three hSWI/SNF proteins with other nuclear compo-
nents. BRG1 and hBRM were not homogeneously distrib-
uted in the nucleus of HeLa cells. Indirect immunofluores-
cent labeling revealed a punctate staining pattern that was
excluded from nucleoli and from regions of very con-
densed chromatin. Little is known about the distribution
of transcription factors in the interphase nucleus. The few
studies that have been published so far show that tran-
scription factors occur in clusters rather than being dif-
fusely distributed throughout the nucleoplasm. Such intra-
nuclear distribution has been described for Rb (Mancini
et al., 1994), p53 (Jackson et al., 1994), GR (van Steensel
et al., 1995b), or RNA polymerase II (van Driel et al.,
1995). In the case of GR, this punctate distribution has
been interpreted as evidence that this factor is present in
the nucleus in many hundreds of clusters of 10–100 recep-
tor molecules each (van Steensel et al., 1995a). These clus-
ters are distributed throughout the nucleoplasm and ex-
cluded from the nucleoli. Earlier studies have shown that
both hBRM and BRG1 proteins enhance transcriptional
activation by GR. It is attractive to speculate that those
genes that require the interplay of both GR and hSWI/
SNF complex are associated with domains that contain
both factors.
Recently, it has been reported that the yeast SWI/SNF
complex copurifies with an active fraction of yeast RNAP
II (Wilson et al., 1996). However, this complex can be also
purified without any associated RNAP II holoenzyme
(Cairns et al., 1994; Côté et al., 1994). In addition, RNAP
II–free SWI/SNF complex functions in conjunction with
nucleosome-bound transcription factors to generate re-
gions of nucleosome disruption (Owen-Hughes et al., 1996).
Our double-immunolabeling experiments using a-BRG1
and  a-hBRM antibodies and two antibodies that recognize
two subpopulations of RNAP II did not reveal strong colo-
calization between the hSWI/SNF complex and RNAP II
(Fig. 1). We cannot rule out the possibility that a fraction of
the hSWI/SNF complex interacts with a fraction of RNAP II
holoenzyme. However, our experiments indicate that a
large fraction of RNAP II is not associated with the major-
ity of the hSWI/SNF complex. This result suggests that the
hSWI/SNF complex can be targeted to particular regions
by interactions with specific transcription factors or DNA
sequences without requiring interaction with RNAP II.
To further monitor the partition of the SWI/SNF com-
Figure 6. In situ, ATP-dependent release of BRG1 and hBRM from the nuclei. HeLa cells grown on coverslips were permeabilized with
CSK 0.5% Triton X-100 buffer and incubated in nuclear buffer with or without 3 mM ATP for 1 h at room temperature. Thereafter,
cells were washed with PBS, fixed with 3% paraformaldehyde, and incubated with the indicated antibodies. Bar, 10 mm.The Journal of Cell Biology, Volume 137, 1997 272
plex in the nucleus, we applied several subnuclear frac-
tionation procedures directed towards the isolation of the
nuclear matrix or nuclear scaffold. DNA binds to nuclear
matrix through regions called MAR or SAR (for review
see Laemmli et al., 1992). These regions are distributed
throughout the genome and organize the chromatin in loops
of variable size. Numerous experiments extend this no-
tion, suggesting a functional role of SARs in gene expres-
sion. SARs are frequently observed in close association
with enhancer elements. In flanking positions, SARs con-
fer elevated and position-independent expression of genes
in homologous as well as heterologous systems (Laemmli
et al., 1992). How SARs activate transcription is not clear;
however, it has been suggested that it may relate to changes
in chromatin structure, affected by factors that bind to
them. Studies by Forrester et al. (1994) indicate that the
IgH locus becomes remodeled and DNase I hypersensitive
at the pre–B cell stage, and that the Em SARs are neces-
sary for this event (Jenuwein et al., 1997). In a number of
cases, SARs have been found at the boundaries of chro-
matin domains as defined by the level of general DNase I
sensitivity (Loc and Strätling, 1988; Levy-Wilson and Fort-
ier, 1990). Taken together, all these data suggest that
SARs and/or their associated proteins are involved in
chromatin remodeling activity. Our experiments clearly
demonstrate that z50% of BRG1 and hBRM and a slightly
lower percentage of hSNF5 proteins are strongly associ-
ated with the nuclear matrix, suggesting that a fraction of
the hSWI/SNF complex is attached to this nuclear struc-
ture. There are several well-characterized SAR binding
proteins. One of these proteins called Bright binds to
SARs placed proximal to the heavy chain enhancer Em of
the IgH gene (Herrscher et al., 1995). Bright binds to the
minor grove of DNA through a DNA binding domain that
shows a significant sequence identity with the yeast SWI1
protein, a component of the yeast SWI/SNF complex
(Herrscher et al., 1995). An homologous domain has also
been identified in other SAR binding proteins. Further-
more, a DNA minor grove binding activity has been re-
cently reported for the yeast SWI/SNF complex (Quinn
et al., 1996). Cross-linking experiments suggest that SWI1
is the protein responsible for this binding activity. It is un-
known if a homologue of SWI1 exists in the human SWI/
SNF complex. However, our results demonstrate that hSWI/
SNF components are present in scaffold preparations, sug-
gesting that the hSWI/SNF complex could contain a SAR
binding protein. An attractive hypothesis is that a fraction
of the hSWI/SNF complex may contain a protein homolo-
gous to SWI1 or Bright that can bind SARs. This SAR-
bound hSWI/SNF complex could be responsible for the
chromatin remodeling activity associated with SAR ele-
ments. Recently, it has been demonstrated that multiple
forms of hSWI/SNF complexes exist, with different sub-
unit composition, in the same cell, as well as different com-
plexes in different cell types (Wang et al., 1996a). Our data
suggest the existence of two subpopulations of the hSWI/
SNF complex, one associated with the nuclear matrix and
another not associated with this nuclear structure.
We further investigated the distribution of the hSWI/
SNF proteins in active and inactive fractions of chromatin.
hBRM, hSNF5 and, to a lesser extent, BRG1 were en-
riched both in chromatin highly accessible to micrococcal
nuclease and in “insoluble chromatin,” or chromatin that
remains bound to the nuclear skeleton. These two frac-
tions (termed S1 and P) were shown to be enriched in
transcriptionally active genes (Rose and Garrard, 1984).
These data agree with our immunolocalization experiments,
showing that BRG1 and hBRM are excluded from hetero-
chromatin. In the fractionation procedure, RNAP II was
found almost exclusively in the P fraction, suggesting that
DNA sequences found in this fraction are being actively
transcribed. We should outline that, even though fraction
S1 was shown to contain DNA from actively transcribed
genes, it lacks RNAP II. Easily solubilized mononucleo-
somes may originate from regions with open chromatin
that are not being transcribed, like enhancers, or from re-
gions in transcribed templates that precede or follow the
actively transcribing RNAP II. Our results suggest that the
hSWI/SNF complex is associated in vivo with regions of
open chromatin where RNAP II is not present, as well as
with DNA segments directly bound by RNAP II. Taken
together, our subnuclear fractionation studies clearly dem-
Figure 7. ATP-dependent release of hBRM from the nuclei requires a hydrolyzable form of ATP. (A) HeLa nuclei were incubated with
3 mM ATP or the same concentration of AMP-PCP or ATPgS. After a 1-h incubation at 308C, nuclei were pelleted, and proteins from
the supernatant (S) or the pellet (P) were electrophoresed and immunoblotted with a-hBRM antibody. (B) HeLa nuclei were incubated as
in A with the indicated kinase inhibitor at 0.1 mM final concentration, except in the case of cdc2 peptide that was used at 0.1 and 10 mM.Reyes et al. Subnuclear Localization of hSWI/SNF Complex 273
onstrate that components of the hSWI/SNF complexes
may be associated with several distinct steps in gene acti-
vation. We can speculate that it may participate in SAR or
MAR function, global chromatin remodeling during gene
activation, and perhaps the transcription initiation process
itself. Further studies will be important to prove our hy-
pothesis and to clarify the exact biochemical role of the
hSWI/SNF complex in transcription control.
We have also investigated the conditions that determine
the binding of hSWI/SNF complex to its targets in the nu-
cleus. The release of SWI/SNF proteins from the tight nu-
clear interaction coincides temporally with the start of mi-
tosis (Fig. 5). This corresponds in time with the onset of
BRG1 and hBRM hyperphosphorylation, suggesting that
either phosphorylation itself or an event linked to this
modification is the cause of the dissociation event. We
found that treatment of permeabilized nuclei with hydro-
lyzable ATP leads to the release of BRG1 and hBRM
from the nuclei. ATP-dependent release was inhibited by
a protein tyrosine kinase inhibitor and a cdc2 substrate
peptide, suggesting that phosphorylation of some nuclear
components is involved in this process. However, released
BRG1 and hBRM were not hyperphosphorylated after
ATP treatment in the same way than they are during mito-
sis. Changes in the activity and morphology of the nucleus
throughout the cell cycle require the nuclear structure to
be dynamic. Phosphorylation appears to be a major con-
trol mechanism of the nuclear skeleton. For example, nu-
clear disassembly is driven by the hyperphosphorylation of
lamin filaments (Fisher, 1987). There is also evidence of
both casein kinase and tyrosine kinase activity associated
with the nuclear matrix (Ohmuda et al., 1986; Tawfic and
Ahmed, 1994). Since both tyrosine kinases and serine- and
threonine-phosphorylating kinases seem to be implicated,
it is possible that ATP-dependent release of hSWI/SNF
complex from its nuclear targets is a consequence of a cas-
cade of kinase activities. It is also possible that this cascade is
involved in the normal cell cycle regulation of the nuclear
structure and may not be specific for the SWI/SNF complex.
Finally, in this work we have analyzed the distribution of
components of the hSWI/SNF complex in different frac-
tions of the nucleus and the chromatin. Numerous obser-
vations indicate a very high level of structural organization
and compartmentalization for the activities occurring within
the nucleus. We think that these structural aspects will be
important factors for the understanding of the mechanism
by which the SWI/SNF complex operates.
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